This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07164/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07164/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07164/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07164/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07164/identifier/chemspider/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07164
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07164 n13:DB07164
dcterms:title
N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
adms:identifier
n9:6918710 n10:99443635 n11:DB07164 n12:5BP n14:5293903
n3:IUPAC-Name
n4:271B504B-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5051-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5050-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B504D-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B504E-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B504F-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5049-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B504A-363D-11E5-9242-09173F13E4C5 n4:271B5047-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5048-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5057-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5058-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5052-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5053-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5055-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5054-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5056-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B505D-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B505F-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5060-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B505C-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B505B-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B505E-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B504C-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5059-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B505A-363D-11E5-9242-09173F13E4C5